Stock Screener
Show:
Sort
Country
Sector
Risk rating
1
2
3
4
5
6
7
Risk factors
Default risk
1
2
3
4
5
6
7
Volatility
1
2
3
4
5
6
7
Stress test
1
2
3
4
5
6
7
Selling difficulty
1
2
3
4
5
6
7
Country risks
1
2
3
4
5
6
7
Other risks
1
2
3
4
5
6
7
Profitability factors
Valuation
1
2
3
4
5
6
7
Analyst view
1
2
3
4
5
6
7
Performance
1
2
3
4
5
6
7
Profitability
1
2
3
4
5
6
7
Growth
1
2
3
4
5
6
7
Dividends
1
2
3
4
5
6
7
Results: 27
Synektik Spólka Akcyjna
SNT.WAMedinice S.A.
ICE.WAMedicalgorithmics S.A.
MDG.WANEUCA S.A.
NEU.WASelvita S.A.
SLV.WARyvu Therapeutics S.A.
RVU.WACaptor Therapeutics Spolka Akcyjna
CTX.WAVoxel S.A.
VOX.WAMultiQure S.A.
PUR.WAScope Fluidics S.A.
SCP.WABioceltix S.A.
BCX.WAMolecure S.A.
MOC.WANanoGroup S.A.
NNG.WAMabion S.A.
MAB.WACelon Pharma S.A.
CLN.WAMercator Medical S.A.
MRC.WASynthaverse S.A.
SVE.WAGenomtec S.A.
GMT.WABIOTON S.A.
BIO.WAPZ Cormay S.A.
CRM.WAPoltreg S.A.
PTG.WABioMaxima S.A.
BMX.WAAirway Medix S.A.
AWM.WAAdiuvo Investments S.A.
ADV.WAPharmena S.A.
PHR.WACentrum Medyczne ENEL-MED S.A.
ENE.WAUrteste S.A.
URT.WA
Return for Q2 2026:11.08%
Portfolio composition:
Return for Q2 2026:7.69%
Portfolio composition: